Stanmore: Creating a Specialty Orthopedics Company

Article preview reprinted from IN VIVO - March, 2009       

Long a pioneer in prosthetics, one of orthopedics' forgotten spaces, Stanmore Implants Worldwide, has a new investor group who hope to transform this once academic supplier into a thriving orthopedics player by focusing on specialty niches that the Ortho giants have largely ignored.     

Stanmore: Creating a Specialty Orthopedics Company

Article preview reprinted from IN VIVO - March, 2009

There was a time—and really not all that long ago—when the orthopedics industry, and in particular, the total joint replacement segment, was defined by its local, small-scale nature. Local suppliers, acting much like design centers and machine shops, turned out implants on behalf of local surgeons with whom they formed close relationships. Even today, the critical importance of independent distribution is, in many ways, a reminder of how important the local and particular have historically been to orthopedics.

All that began to change dramatically two decades ago with the boom in total hip and knee replacements, as large-scale production and mass marketing became increasingly important—a phenomenon not at all rare in business broadly speaking. Moreover, as orthopedics companies found striking success in the total joint market, the natural trajectory of those successful businesses pushed them toward larger-scale production and broader strategic visions. Still, even as recently as a couple of years ago, it wasn't hard to find senior executives in the orthopedics industry dismissing the importance of scale and critical mass in orthopedics, particularly when weighed against things such as close relationships with surgeons and technology advances—this, even as the waves of consolidation and concentration in the industry (and the myriad rumors suggesting other combinations) belied the avowed irrelevance of critical mass.

Purchase this article online as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed. Subscribe to IN VIVO.

Companies mentioned in this article:

Baxter International Inc.

Hanger Orthopedic Group Inc.

Johnson & Johnson

MDY Healthcare PLC

Medivance Inc.

Medtronic Inc.

Kyphon Inc.

Olympus Corp.

Gyrus Group PLC

Ossur HF

Small Bone Innovations LLC

Smith & Nephew PLC

Stanmore Implants Worldwide Ltd.

Stryker Corp.

Stryker Orthopedics

Tornier SA

Wright Medical Group Inc.

Cremascoli Ortho SPA

Zimmer Holdings Inc.

IN VIVO delivers:

• Revealing, in-depth coverage of your competitors' strategies
• Incisive projections of future industry trends and their implications for your business
• Expert analysis of key industry developments
• Exclusive interviews with top industry executives and analysts
• In-depth examination of dealmaking, marketing, R&D, regulatory, and finance strategies -- those that were successful and those that missed the mark
• Subscribe to IN VIVO today!